People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

29 Aug 2014
Price Change (% chg)

$0.37 (+1.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Biggar, Stephen 

Brief Biography

Dr. Stephen R. Biggar, M.D., Ph.D., is Independent Director of Acadia Pharmaceuticals Inc. Dr. Biggar is an employee at Baker Brothers Advisors LP, a registered investment adviser focused on long-term investments in life-sciences companies. Dr. Biggar joined Baker Brothers Advisors in 2000. Dr. Biggar also serves as a director for Synageva BioPharma Corp., a publicly traded biotechnology company. The NCG Committee believes that Dr. Biggar’s scientific background and financial industry experience make him a valuable contributor to Board discussions. Dr. Biggar received an M.D. and a Ph.D. in Immunology from Stanford University and received a B.S. in Genetics from the University of Rochester.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leslie Iversen


Uli Hacksell


Stephen Davis


Roger Mills


Terrence Moore


Glenn Baity

As Of 30 Dec 2013
Search Stocks